BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19319460)

  • 1. Natural and synthetic regulators of embryonic stem cell cardiogenesis.
    Willems E; Bushway PJ; Mercola M
    Pediatr Cardiol; 2009 Jul; 30(5):635-42. PubMed ID: 19319460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes.
    Binah O; Dolnikov K; Sadan O; Shilkrut M; Zeevi-Levin N; Amit M; Danon A; Itskovitz-Eldor J
    J Electrocardiol; 2007; 40(6 Suppl):S192-6. PubMed ID: 17993321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemical biology approach to myocardial regeneration.
    Willems E; Lanier M; Forte E; Lo F; Cashman J; Mercola M
    J Cardiovasc Transl Res; 2011 Jun; 4(3):340-50. PubMed ID: 21424858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human embryonic stem cells for myocardial regeneration.
    Kehat I; Gepstein L
    Heart Fail Rev; 2003 Jul; 8(3):229-36. PubMed ID: 12878831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
    Zhang F; Pasumarthi KB
    BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human embryonic stem cell-derived cardiomyocytes for heart therapies.
    Siu CW; Moore JC; Li RA
    Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):145-52. PubMed ID: 17584049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
    Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation.
    Kim C; Majdi M; Xia P; Wei KA; Talantova M; Spiering S; Nelson B; Mercola M; Chen HS
    Stem Cells Dev; 2010 Jun; 19(6):783-95. PubMed ID: 20001453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction.
    Rajasingh J; Bord E; Hamada H; Lambers E; Qin G; Losordo DW; Kishore R
    Circ Res; 2007 Oct; 101(9):910-8. PubMed ID: 17823373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of histamine/H
    Zhu X; Ding S; Li H; Zhang Z; Xu L; Wu J; Wang X; Zou Y; Yang X; Ge J
    Stem Cell Res Ther; 2020 Mar; 11(1):27. PubMed ID: 32127042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
    Yoshida Y; Yamanaka S
    Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
    [No Abstract]   [Full Text] [Related]  

  • 14. Parthenogenetic stem cells for tissue-engineered heart repair.
    Didié M; Christalla P; Rubart M; Muppala V; Döker S; Unsöld B; El-Armouche A; Rau T; Eschenhagen T; Schwoerer AP; Ehmke H; Schumacher U; Fuchs S; Lange C; Becker A; Tao W; Scherschel JA; Soonpaa MH; Yang T; Lin Q; Zenke M; Han DW; Schöler HR; Rudolph C; Steinemann D; Schlegelberger B; Kattman S; Witty A; Keller G; Field LJ; Zimmermann WH
    J Clin Invest; 2013 Mar; 123(3):1285-98. PubMed ID: 23434590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
    Tiburcy M; Hudson JE; Balfanz P; Schlick S; Meyer T; Chang Liao ML; Levent E; Raad F; Zeidler S; Wingender E; Riegler J; Wang M; Gold JD; Kehat I; Wettwer E; Ravens U; Dierickx P; van Laake LW; Goumans MJ; Khadjeh S; Toischer K; Hasenfuss G; Couture LA; Unger A; Linke WA; Araki T; Neel B; Keller G; Gepstein L; Wu JC; Zimmermann WH
    Circulation; 2017 May; 135(19):1832-1847. PubMed ID: 28167635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating the naturally occurring process for repair of damaged heart.
    Li M; Ng SC
    Curr Pharm Des; 2014; 20(12):1950-63. PubMed ID: 23844738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating Cardiogenesis as a Treatment for Heart Failure.
    Heallen TR; Kadow ZA; Kim JH; Wang J; Martin JF
    Circ Res; 2019 May; 124(11):1647-1657. PubMed ID: 31120819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications.
    Vidarsson H; Hyllner J; Sartipy P
    Stem Cell Rev Rep; 2010 Mar; 6(1):108-20. PubMed ID: 20091143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to make a cardiomyocyte.
    Später D; Hansson EM; Zangi L; Chien KR
    Development; 2014 Dec; 141(23):4418-31. PubMed ID: 25406392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocytes from human embryonic stem cells.
    Passier R; Denning C; Mummery C
    Handb Exp Pharmacol; 2006; (174):101-22. PubMed ID: 16370326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.